Vascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcoma
Pediatric Blood & Cancer, 05/04/2012Schiavetti A et al.
Circulating Vascular Endothelial Growth Factor (VEGF) is significantly increased in pediatric patients with newly diagnosed rhabdomyosarcoma (RMS). Further studies in larger series of RMS patients are needed to understand whether measurements of circulating VEGF might have a role in assessing prognosis and modulating treatment.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.